Found: 6
Select item for more details and to access through your institution.
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1134436
- By:
- Publication type:
- Article
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.956825
- By:
- Publication type:
- Article
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials.
- Published in:
- Nutrients, 2023, v. 15, n. 14, p. 3249, doi. 10.3390/nu15143249
- By:
- Publication type:
- Article
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL.
- Published in:
- Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1229304
- By:
- Publication type:
- Article
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.824511
- By:
- Publication type:
- Article
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1566, doi. 10.3390/ph16111566
- By:
- Publication type:
- Article